Pharma Journalist -

AstraZeneca announced that it has agreed to buy a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) for a total cash consideration of $95m from a subsidiary of Swedish…
Read More...

AstraZeneca announced that its partner FibroGen (China) Medical Technology Development Co., Ltd. (FibroGen China) has received marketing authorisation for roxadustat in China for the…
Read More...

Iconic Therapeutics, a private biopharmaceutical company focused on novel therapeutics for serious diseases such as cancer and age-related macular degeneration (AMD), announced that the…
Read More...

Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO Impulse System for treatment of STEMI…
Read More...

Enteris BioPharma announced its entry into a definitive licensing agreement with Cara Therapeutics (Nasdaq: CARA) for Enteris' Peptelligence technology in the ongoing development of an…
Read More...

SMi Reports: Conference chair, Michel Mikhail, gives four key reasons to attend the Biosimilars conference this September The 10th Annual Biosimilars conference is set to take place…
Read More...

TOKYO & Astellas Pharma Inc. and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application…
Read More...

Pfizer announced an additional half billion dollar investment for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford, North Carolina. This facility…
Read More...

Innovent Biologics, Inc. (Innovent) announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for the development and potential commercialization of…
Read More...

Enable Injections, Inc. (Enable), a company developing and manufacturing investigational wearable infusion devices for combination products, announced it has entered into a development…
Read More...